Explore

Rapid Read Rapid Read
UVA Health Researchers Explore Sound Wave Technique for Brain Tumor Treatment

UVA Health Researchers Explore Sound Wave Technique for Brain Tumor Treatment

Researchers at UVA Health have discovered that focused sound waves may enhance drug delivery to brain tumors, specifically gliomas, which are the most common primary brain tumors in adults. This innovative approach uses microbubbles activated by sound waves to open the blood-brain barrier, allowing drugs to target tumor cells more effectively. The study, conducted by the Focused Ultrasound Cancer Immunotherapy Center, indicates that gliomas might be more receptive to this method than previously thought. The research also identifies an optimal size range for drug molecules, suggesting that medium-sized molecules are most effective in penetrating the tumor cells. This development is part of UVA's broader efforts to improve cancer treatment through advanced technologies.
Rapid Read Rapid Read
Glioblastoma Patients Face Barriers in Accessing Comprehensive Care

Glioblastoma Patients Face Barriers in Accessing Comprehensive Care

A recent account highlights the challenges faced by glioblastoma patients in accessing comprehensive care in the U.S. The story, shared by a family member of a patient, underscores the systemic issues in communication and access to care for those diagnosed with this aggressive form of brain cancer. Despite the availability of advanced scientific resources in the U.S., many patients and their caregivers report a lack of information about clinical trials, second opinions, and palliative care options. The narrative reveals that two-thirds of surveyed glioblastoma patients were never offered a clinical trial, and more than half were not encouraged to seek a second opinion. Additionally, a significant number of patients were not informed about tumor testing or tissue preservation, and over 70% had no meaningful involvement with palliative or hospice care. These gaps in communication and access are not attributed to a lack of scientific advancement but rather to failures in the healthcare system's ability to eff...
Rapid Read Rapid Read
Iowa's Rising Cancer Rates Prompt Public Health Concerns and Research Initiatives

Iowa's Rising Cancer Rates Prompt Public Health Concerns and Research Initiatives

Iowa has been identified as having the second-highest rate of new cancer cases in the United States, a situation that has been escalating since 2013. This alarming statistic has become a focal point in public policy and healthcare discussions across the state. Mary Charlton, who leads the Iowa Cancer Registry, has been actively involved in tracking these cases and providing annual reports. The rising cancer rates have been linked to environmental risk factors, particularly in the Des Moines area, where issues such as watering bans and nitrates in the water have been highlighted. Researchers are currently investigating the primary causes of cancer in Iowa, with a comprehensive report expected to be submitted to the state in August as part of the Key Drivers of Cancer in Iowa Project.
Rapid Read Rapid Read
University of Oxford Launches Genomics-Led Program to Improve Childhood Cancer Treatments

University of Oxford Launches Genomics-Led Program to Improve Childhood Cancer Treatments

The University of Oxford has initiated a new program aimed at enhancing treatments for childhood cancer through the integration of genomics, data science, and clinical research. This initiative, supported by the UK charity Little Princess Trust, seeks to develop safer and more effective therapies for pediatric oncology. Professor Isidro Cortés-Ciriano has been appointed as the first Little Princess Trust Professor of Paediatric Oncology to lead this effort. The program focuses on precision medicine, tailoring treatments to the genetic and molecular characteristics of each tumor. Oxford's platform, with over 900 cancer researchers, aims to accelerate the transition from discovery to patient treatment, emphasizing reduced toxicity in therapies.
Rapid Read Rapid Read
CommonSpirit Health's Oncology Clinic RN Role Highlights Commitment to Patient Care

CommonSpirit Health's Oncology Clinic RN Role Highlights Commitment to Patient Care

CommonSpirit Health is seeking an Oncology Clinic Registered Nurse (RN) to provide specialized care to adult oncology and hematology patients. This role is crucial for ensuring patient safety and compliance, requiring the nurse to make autonomous decisions within their scope of practice, especially in the absence of a physician. The RN will administer various medications, including chemotherapy, and document all care meticulously. The position demands a Registered Nurse license in Washington and ideally an Oncology Certified Nurse credential. The role emphasizes cultural sensitivity, effective communication, and professional growth, aligning with CommonSpirit Health's mission to deliver compassionate care.
Trendline Trendline
Nicole 'Snooki' Polizzi Shares Emotional Update After Hysterectomy for Cervical Cancer

Nicole 'Snooki' Polizzi Shares Emotional Update After Hysterectomy for Cervical Cancer

Nicole 'Snooki' Polizzi Shares Emotional Update After Hysterectomy for Cervical Cancer
Rapid Read Rapid Read
Environmental Factors Linked to Rising Cancer Rates in Iowa

Environmental Factors Linked to Rising Cancer Rates in Iowa

In Iowa, environmental factors such as water, air, and soil pollution are contributing to the state's rising cancer rates, according to a report by the Iowa Environmental Council. Iowa has the second-highest cancer rate in the U.S., with pollutants like nitrates, pesticides, radon, and PFAS identified as key contributors. These pollutants are prevalent in local rivers and air, particularly affecting Scott County. The report highlights the need for residents to test their homes for radon and water for nitrates, as well as advocating for policy changes to address these environmental risks.
Rapid Read Rapid Read
Study Links Fructose to Metastasis in Aggressive Ovarian Cancer

Study Links Fructose to Metastasis in Aggressive Ovarian Cancer

A study published in Nature Aging reveals that fructose may play a role in promoting metastasis in high-grade serous ovarian cancer (HGSOC), the most common type of ovarian cancer. Researchers found that cancer cells surviving chemotherapy use fructose as a signaling molecule, potentially driving cancer recurrence. The study highlights that fructose, abundant in the signaling molecules released by senescent cancer cells, can cause cancer cells to detach and metastasize. The findings suggest a possible link between high fructose consumption and cancer progression, raising questions about dietary interventions to reduce metastasis risk.
TheStreet TheStreet
J&J’s biotech progress could punish its 2027 profit

J&J’s biotech progress could punish its 2027 profit

Johnson & Johnson (JNJ) just issued one of the weirdest profit warnings in health care. The biotech business decreased its 2026 adjusted earnings guidance to between $10.96 and $11.11 a share, from a range of $11.60 to $11.75. This year, the newly closed acquisition of Firefly Bio and the ...
Trendline Trendline
Biotechnology Companies Invest in Base Editing to Enhance Genetic Disorder Treatments

Biotechnology Companies Invest in Base Editing to Enhance Genetic Disorder Treatments

Biotechnology Companies Invest in Base Editing to Enhance Genetic Disorder Treatments
Rapid Read Rapid Read
AI Revolutionizes Clinical Trial Design and Patient Selection in Cancer Immunotherapy

AI Revolutionizes Clinical Trial Design and Patient Selection in Cancer Immunotherapy

Artificial intelligence (AI) is significantly transforming the landscape of cancer immunotherapy by enhancing clinical trial design and patient selection processes. AI tools are being utilized to analyze historical trial data and real-world evidence, which helps in estimating the success chances of trials and suggesting optimal endpoints or dosing strategies. This technology is particularly beneficial in immuno-oncology, where complex biomarker criteria and slow enrollment have been persistent challenges. AI-powered trial matching tools can automatically scan patient medical records, including genomics, against trial criteria, thereby increasing enrollment rates significantly. Additionally, AI refines inclusion criteria by simulating virtual cohorts to predict which biomarker combinations or patient features lead to higher response rates, thus guiding more precise enrollment criteria and more efficient trials.
Trendline Trendline
Moderna's Norovirus Vaccine Trial Faces Setback, Extends into Fourth Season

Moderna's Norovirus Vaccine Trial Faces Setback, Extends into Fourth Season

Moderna's Norovirus Vaccine Trial Faces Setback, Extends into Fourth Season